Pablo L, Garay Aramburu G, García Layana A, Fernandez A, Vázquez I, Acebes X, Zulueta J, Balonga D, Salinas Ortega L , Muñoz A ,Casado Gómez A , Casado MA , Salvador J, Banon Rodriguez I, Ruiz Moreno JM
Assessing the economic burden of vision loss and irreversible legal blindness in Spain (2021–2030): a societal perspective
Health Econ Rev. 2024 Sep 3;14(1):70
Flor-Lorente B, Noguer-Aguilar JF, Delgado-Rivilla S, García-González JM, Rodriguez-Martín M, Salinas-Ortega L, Casado MA, Álvarez M
The economic impact of anastomotic leak after colorectal cancer surgery
Health Econ Rev 13, 12 (2023)
Gros B, Galan A, Gonzalez-Parra E, Herrero JA, Echave M, Vegter S, Tolley K, Oyagüez I
Cost effectiveness of Lanthanum Carbonate in chronic kidney disease patients in Spain before and during dialysis
Health Econ Rev. 2015;5:14 doi:10.1186/s13561-015-0049-3
Sanchez-de la Rosa R, Sabater E, Casado MA
Cost analysis of glatiramer acetate vs. Fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis in Spain
Health Econ Rev. 2013;3:13 doi:10.1186/2191-1991-3-13
Homar F, Lozano V, Martínez-Gómez J, Oyagüez I, Pareja A, Payeras A, Serrano J, Carmen Carratalá, Casado MA
Cost analysis of HIV treatment and drug-related adverse events when fixed-dose combinations of antiretrovirals (FDCs) were stopped, versus continuation with FDCs
Health Econ Rev. 2012,2:16
García-Ruiz A, Perez-Costillas L, Montesinos AC, Alcalde J, Oyagüez I, Casado MA
Efficiency of antipsychotics in reducing schizophrenia relapses
Health Econ Rev. 2012;2:8
Martínez-Raga J, González-Saiz F, Oñate J, Oyagüez I, Sabater E, Casado MA